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Introduction
Excessive and prolonged activation of monocytes/macrophages inflicts sustained tissue damage and targets organ inflammation. How the complex networks of survival and apoptotic regulators are integrated to tightly control the lifespan of infiltrating monocytes to avoid harmful reactions and allow healing and maintenance of tissue homeostasis remains elusive.
Mitochondria play a pivotal role in innate immune cell homeostasis by supplying energy and integrating converging signals that lead to apoptosis or inflammation. 1, 2 In particular, the mitochondrial network is crucial for cell homeostasis, as the balance between fusion and fission is essential for mitochondria biogenesis and removal, optimized redistribution of mitochondria in response to local demand of ATP production, and progression of apoptosis. 3 Furthermore, mitochondria dysfunction is frequently associated with pathological conditions, including cancer and inflammatory disorders. 4, 5 The mechanisms that control mitochondrial activity and dynamics are however not fully understood.
Micro(mi)-RNAs are endogenous short non-coding RNA molecules that control gene expression mainly at the post-transcriptional level by pairing to the target transcripts. 6 They participate in all the biological functions that have been investigated so far and dysfunction of miRNAs is implicated in major human disorders, including cancer and autoimmunity. [7] [8] [9] The function of most of the mammalian miRNAs has yet to be determined. There is growing interest in exploring regulation of mitochondria by miRNAs. Few miRNAs have been demonstrated to control mitochondrial metabolism and dynamics, as well as mitochondriamediated apoptosis. In addition, outer membrane of mitochondria is one of the destinations of miRNAs. 10 Among miRNAs that have been assigned apoptotic and immune functions, and that regulate nuclear encoded mitochondria-associated proteins, miR-125b is of particular interest. 11 It is a highly conserved miRNA that has multiple targets, including proteins regulating apoptosis,
For personal use only. on August 31, 2017. by guest www.bloodjournal.org From innate immunity, inflammation, and differentiation, and its dysregulation has been reported to occur in multiple cancer types. [12] [13] [14] [15] [16] [17] Depending on the cellular context, miR-125b shows different patterns of expression and effects, acting as tumour suppressor gene or as oncogene through the regulation of multiple genes involved in the mitochondrial pathways of apoptosis. [18] [19] [20] [21] In hematopoietic stem cells miR-125b is highly expressed, enhancing selfrenewal and survival while providing resistance to apoptosis and blocking differentiation, and is up-regulated in lymphoblastic and myeloblastic leukemia. 22 Importantly, miR-125b plays a critical role in myeloid biology, 23 its expression being low in common myeloid progenitors, 22 induced upon inflammatory stimuli in macrophages 24, 25 and deregulated in myeloid malignancies. 15, 26 Finally, miR-125b regulates adaptation of cell metabolism to cancer transformation 27 and is one of the master miRNAs involved in the TLR4 signaling pathway during the development of endotoxin tolerance.
25,28
To provide novel insight into the integrated genetic regulatory network specifying cell fate, we have searched for novel target genes of miR-125b and further explored its role in the context of human monocytes, including the mechanisms on mitochondria metabolism. NCT02909998). Fresh peripheral blood was obtained from 6 healthy donors with no history of autoimmune diseases (75% of woman) and from 8 age-and sex-matched patients with RA (Table I) .
Gene expression analysis
Total RNAs were extracted using a miRNeasy Mini Kit with a Qiacube (QIAGEN).
Expression levels of miRNAs and mRNAs were quantified using the TaqMan microRNA and gene expression assays (Life Technologies). The expression of RNU6B and GAPDH was used as endogenous control for miRNA and mRNA data normalization, respectively. Specific primers were used for quantification (Table S1 ). TaqMan® Array Human Inflammation Panel (Life Technologies) was used according to the manufacturer's protocols and relative gene expression was calculated using the comparative threshold cycle (C T ) method. 3'UTR (see supplemental information), together with 1 to 100 nM of pre-or antago miR125b. Luciferase activity was measured 48 hours using Dual-luciferase Reporter Assay System (Promega). Normalization was performed with the number of living cells.
Protein extraction and western blotting
Cells were lysed with CelLytic TM MT (Sigma-Aldrich). Proteins were separated on NuPAGE® 12% Bis-TRIS gels (10 µg/lane) and transferred to nitrocellulose membranes, which was blocked with primary antibody. Anti-BIK antibody was purchased from Santacruz and anti-MTP18 antibody was kindly provided by Dr. Daniel Tondera (Silence Therapeutics, Berlin, Germany). Table S2 describes the antibodies and dilutions used for the immunoblot analysis. Proteins were visualized and quantitated using the Odyssey Infrared
Imaging System (LI-COR Biosciences). Autophagy and autophagic flux were assessed according to previously reported methods. 
Fluorescence microscopy
THP-1 and CD14 + cells were seeded at 50% confluence, treated 12 hours with PMA (0.1 μ g/ml) and fixed with 4%, permeabilized in 0.2% Triton X-100 and incubated in blocking solution (DAKO) before staining with TOM20 and secondary antibody Alexa ® 488. Cells were visualized using a Leica TCS SP5 confocal laser-scanning microscope model DM 6000S and the LAS AF acquisition software (Wetzlar, Germany). Images were captured on the Cellomics ArrayScan VTi platform (Thermo Scientific) using the cell health-profiling algorithm to quantify the percentage of cells containing Tom20 mitochondrial staining.
Cell viability and apoptosis assay
Cytotoxic effects and Caspase 3/7 activation were measured 48 hours post-transfection using CellTiter-Glo® Reagent (Promega) and the Caspase-Glo 3/7 Assay (Promega), respectively.
Microarray hybridization and data analysis
Quality control and quantification of total RNA was ensured with Bioanalyser (Agilent Technologies) and NanoDrop ND-1000 (Thermo Scientific), respectively. The generation of cRNA, sample hybridisation (using Affymetrix HG U133 plus 2.0 arrays) and scanning with a GeneChip Scanner 3000 (Affymetrix) were performed as described previously. 31 Data from three pairs of conditions were analyzed using BioRetis database (supplemental information).
The chip data discussed in this publication have been deposited in NCBI's Gene Expression
Omnibus and are accessible through GEO Series accession number GSE62693. were significantly up or downregulated in cells transfected with miR-125b mimics as compared with control conditions. We selected mRNAs with fold change (FC) higher than 1.5, p-value less than 0.05 and false discovery rate less than 5% ( Figure 1A ). DAVID 32 analysis revealed high enrichment of specific biological processes including apoptosis, inflammation, and immune responses ( Figure 1B) . Selecting the specific down-regulated mRNAs in cells overexpressing miR-125b, we identified four putative miR-125b gene targets predicted by two major target prediction algorithms (microRNA.org and TargetScan). All putative target genes were involved in the apoptosis pathway: TMEM77 (alias DRAM2), HTATIP2 (alias TIP30), MTP18 (alias MTFP1), and BIK.
BIK and MTP18 are two novel targets for miR-125b
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The 3'UTR of the four predicted targets were cloned downstream from luciferase gene, HEK-293 cells were co-transfected with the synthetic miR-125b precursor or antagonist, and relative luciferase activities were determined ( Figure 1C -H and Supplementary Figure S1 ).
Over-expression of miR-125b only significantly decreased the luciferase activity of the BIK and MTP18 reporter systems. For both cases, increasing doses of miR-125b antisense dosedependently reversed the inhibitory effect of basal miR-125b expression on the reporter system. To prove that miR-125b regulates endogenous BIK and MTP18 mRNA expression in monocytes, we transfected THP-1 cells with synthetic miR-125b precursor or antagonist. Data revealed that BIK and MTP18 mRNA and protein levels were significantly reduced by enforced expression of miR-125b to levels comparable with BIK and MTP18 siRNAmediated knockdown ( Figure 1E -H).
miR-125b promotes apoptosis of monocytes
BIK is a BH3-only pro-apoptotic protein localized in the endoplasmic reticulum that sensitizes mitochondrial apoptosis.
33 MTP18 is localized in the mitochondria and induces mitochondrial fission and apoptosis. 34 Since miR-125b targets two pro-apoptotic genes, we studied the effect of miR-125b on THP-1 apoptosis. Unexpectedly, enforced expression of miR-125b, as well as BIK or MTP18 siRNAs, induced apoptosis as determined by decreased cell viability and increased caspase 3/7 activation (Figure 2A-B) . To further understand the functional role of miR-125b in apoptosis, we quantified several other anti-and pro-apoptotic genes that have been previously identified as directly targeted by miR-125b. The quantification of mRNA and protein levels revealed that BAK1, BMF, and BCL-2 expression
were not controlled by miR-125b in THP-1 (Supplementary Figure S2) .
As BIK can induce autophagy by displacing Bcl-2 from Beclin 1 and NAF-1 35-38 we investigated the effect of miR-125b on autophagy. We first analyzed the accumulation of LC3-II, which reflects the number of autophagosomes. 39 Neither the over-expression of miR125b nor the silencing of BIK modified the levels of LC3-II as compared with controls ( Figure 2C ). Second, to assess modulation of the autophagic flux, we analyzed the expression of the autophagic cargo SQSTM1/p62. The expression levels of SQSTM1/p62 mRNA and protein were unaltered in all conditions tested ( Figure 2C-D) . Overall these results strongly suggest that miR-125b does not modulate autophagy in THP-1 cells.
miR-125b dampens mitochondrial respiration rate
To further explore the underlying mechanisms by which miR-125b-mediated silencing of BIK Overall, our data suggest that miR-125b induces apoptosis in THP-1 by regulating mitochondrial respiration, at least in part through BIK silencing, but not through MTP18
silencing.
Increase of mitochondrial fusion by miR-125b
As BIK activates mitochondrial fragmentation with little release of cytochrome c to the cytosol 40, 41 and MTP18 loss-of-function promotes fusion of mitochondria, 42 we assessed the mimics together with mock-or BIK-expressing plasmids significantly increased the mitochondrial fusion rate, rescue of MTP18 expression restored fusion to levels comparable to the control condition ( Figure S4G ). In addition, rescue of MTP18 expression significantly increased the mitochondrial fission rate as compared with the 3 other conditions ( Figure   S4H ). These results suggest that miR-125b regulates mitochondrial fusion at least in part through MTP18 silencing, but not through BIK silencing.
TLR4 engagement induces the miR-125b-mediated silencing of BIK
LPS is a potent activator of monocytes that controls survival and apoptosis through TLR4 Thus, blocking LPS-induced miR-125b increase preserved the reserve respiratory capacity of the cells. Altogether, these data suggest that miR-125b regulates metabolic adaptation of monocytes to inflammation.
miR-125b promotes classical proinflammatory activation of THP-1 cells
To further explore the mechanisms of miR-125b-induced metabolic adaptation to inflammation, we quantified a set of genes implicated in the inflammatory response ( Figure   4A ). Following miR-125b enforced expression, a variety of genes were elevated as compared with miR-125b inhibition, particularly chemokines and proinflammatory mediators: CXCL10, CXCL11, TNF, and NOS2A genes. All these genes provide a likely mechanism for the THP-1
For personal use only. on August 31, 2017. by guest www.bloodjournal.org From cells that occurs following increased miR-125b expression, as they are indicative of the M1-type polarization known to induce distinct genetic and metabolic profiles, switching metabolism from oxidative phosphorylation to glycolysis and triggering specific proinflammatory cytokines. 44 To induce classic (M1) polarization, PMA differentiated-THP-1 macrophages (Mφ) were incubated in the presence of IFN-γ plus LPS. 45 Polarization was first confirmed using a panel of established markers ( Figure 4B ) and second by real-time monitoring of the mitochondrial energy metabolism ( Figure 4C ). M1-polarized THP-1 macrophages showed increased expression of TNF, CXCL10, and CXCL11, as well as decreased OCR, compared with M0 or Mφ. As previously reported for mouse monocytes, 14 we observed enhanced miR-125b expression in THP-1 macrophages (Mφ), that is maintained when polarized into M1-like macrophages ( Figure 4D ). These data suggest that miR-125b may be involved in the induction and maintenance of the activated nature of macrophages.
Since the expression of BIK and MTP18 in M1-like macrophages was inversely correlated to that of miR-125b ( Figure 4D ), we determined the effects of M1 polarization on mitochondria respiration and dynamics. We showed that M1 polarization reproduces the effect of miR-125b overexpression or BIK silencing on the mitochondrial respiration of macrophages ( Figure 2E and 3G), and the effect of miR-125b overexpression or MTP18 silencing on the mitochondrial dynamics ( Figure 2C Finally, we tested the mechanisms of miR-125b-mediated metabolic adaptation to inflammation in human primary monocytes. We showed that purified CD14 + monocytes challenged with LPS displayed reduced OCR ( Figure 5A -B) and increased mitochondrial fusion ( Figure 5C ). Furthermore, LPS induced the rapid increase in the miR-125b expression level, which is associated with reduced MTP18 and BIK expression levels, as well as parallel increased expression of the proinflammatory TNF cytokine and CXCL11 chemokine ( Figure   5D ). These data support the hypothesis that metabolic adaptation of CD14 + monocytes to inflammatory stimulus involves the control of mitochondrial respiration and dynamics through miR-125b/BIK/MTP18 axis.
We then analyzed the expression profile relationships between miR-125b and its target genes on monocytes in the context of a systemic inflammatory disorder. As CD14 + monocytes are important contributors to inflammation in patients with rheumatoid arthritis (RA) through the production of proinflammatory cytokines, we determined whether miR-125b-mediated regulation of BIK and MTP18 expression was affected on activated monocytes. In CD14 + blood monocytes from RA subjects, miR-125b exhibited decreased expression as compared with healthy controls ( Figure 5E ), and was inversely correlated with BIK (r=0.46, p=0.032) and MTP18 mRNA (r=0.19) expression, while no correlation was found in CD14 + monocytes isolated from healthy donors ( Figure 5F ). Co-factors could not account for the observed modifications (data not shown). The observation of a reduced expression of the pro-apoptotic miR-125b in CD14 + monocytes from RA patients is consistent with previous findings
+ monocytes are resistant to oxidative stress and to apoptosis, and thus abundantly present in RA tissues.
46,47

Discussion
Our present work identifies the endoplasmic reticulum BH3-only protein BIK and the mitochondrial fission process 1 protein (MTFP1, also known as MTP18) as two novel cellular targets of miR-125b. In addition, we show that increased miR-125b through TLR4 affects mitochondrial respiration and dynamics through BIK and MTP18 silencing, respectively, promoting pro-inflammatory activation and apoptosis of monocytes ( Figure 6 ). Our data suggest a novel role for miR-125b in regulating metabolic adaptation of monocytes to inflammation, thus extending its involvement in cell biology and disease pathogenesis as well as providing potential candidates for therapeutic intervention. We showed that response to TLR4 agonist is accompanied by a decrease in mitochondrial respiration, and that this effect is reversed when miR-125b is blocked. We also showed that miR-125b alone mimics metabolic adaptation of monocytes to TLR4 ligation as evidenced by decreased OCR. More specifically, miR-125b
regulates the spare respiratory capacity, which represents the amount of extra ATP that can be produced by OxPhos in case of a sudden increase in energy demand, permitting rapid adaptation to metabolic changes. If the respiratory reserve is not sufficient to provide the cellular ATP levels required, cells are induced to apoptosis. This is consistent with our observation that miR-125b ectopic expression reduces cell proliferation and promotes apoptosis, while miR-125b blockade prevents cells from apoptosis. Although observed in a different cell context, miR-125b was recently reported to induce loss of mitochondrial membrane potential and sensitization to apoptosis in human breast cancer cell line.
20
In addition to identifying a miR-125b/BIK/MTP18 pathway controlling energy production and cellular survival in human monocytes, our work also substantially clarifies the nature of the complex crosstalk between ER and mitochondria in human monocytes. The pro-apoptotic proteins BAK1, BMF, PUMA and p53, and the anti-apoptotic protein MCL-1, BCL-W and Understanding how immune cells commit to particular microenvironment and metabolic fates, and the immunologic consequences of reaching a metabolic endpoint is key. Here, we provide molecular clues for miR-125b involvement on the complex metabolic adaptation of human monocytes when activated by LPS and polarized towards M1 phenotype. Our data suggest that miR-125b contributes to inflammation by controlling mitochondria integrity through BIK and MTP18 silencing to adapt oxygen consumption and mitochondrial dynamics of monocytes to environmental cues. These results identify important mechanistic connections between microRNAs and mitochondrial functions, with broad implications for cellular metabolism and adaptation to cellular stress, and deepen our understanding of the molecular events of human monocyte biology. ACPA: Anti-citrullinated protein antibodies ; RF : Rheumatoid factor ; DAS28 : Disease activity score refering to the 28 joints examined.
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